Aleksandra Kułakowska | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Aleksandra Kułakowska
University of Opole

Aleksandra Kułakowska
Affiliation University of Opole
Country Poland
Documents 9
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-5466-7167

Aleksandra Kułakowska is a researcher affiliated with the University of Opole whose scholarly work contributes to contemporary discussions in medicine, public health, patient care, and clinical practice. Her publications explore diverse healthcare topics including nephrology, cardiology, dermatology, women’s health, infection prevention, and quality-of-life assessment. Through peer-reviewed academic articles, she has participated in the dissemination of evidence-based medical knowledge and interdisciplinary healthcare perspectives.[1]

Abstract

This article presents an overview of the academic profile and scholarly contributions of Aleksandra Kułakowska. Her published work addresses clinically relevant healthcare challenges, emphasizing patient well-being, disease management, preventive medicine, and evidence-based healthcare practices. The breadth of topics represented within her publication portfolio demonstrates engagement with multidisciplinary medical research and healthcare education.[2]

Keywords

Medicine, Health Sciences, Clinical Research, Patient Care, Public Health, Dialysis, Medical Education, Healthcare Quality.

Introduction

Healthcare research plays an important role in improving patient outcomes and informing clinical decision-making. Aleksandra Kułakowska’s academic contributions align with this objective by addressing issues related to chronic disease management, healthcare quality, and patient-centered care. Her work contributes to broader efforts aimed at enhancing understanding of medical conditions and treatment outcomes.[3]

Research Profile

The research interests of Aleksandra Kułakowska encompass several areas of medicine and health sciences. Her publications address dialysis and quality of life, mental health implications of chronic treatment, surgical site infection prevention, women’s health, cardiovascular disorders such as Brugada syndrome, and rare dermatological conditions including Schnitzler syndrome. These studies demonstrate interdisciplinary engagement with contemporary healthcare topics.[4]

Research Contributions

  • Evaluation of quality-of-life outcomes among dialysis patients.
  • Assessment of mental health considerations associated with chronic renal therapy.
  • Review of updated guidelines concerning surgical site infections.
  • Analysis of healthy lifestyle interventions for patients experiencing PMS symptoms.
  • Compilation of clinically relevant information regarding Brugada syndrome.

Publications

  • Schnitzler syndrome – a rare cause of chronic urticaria. Case report (2025).
  • What impact does dialysis have on the patient’s life and mental health? (2023).
  • Dialysotherapy effect on the quality of life for renal patients (2023).
  • Surgical site infections – an updated review of guidelines (2023).
  • Holistic care, physical activity and healthy lifestyle in PMS patients (2023).

Research Impact

The published studies contribute to healthcare education and clinical awareness by synthesizing current evidence and discussing practical implications for patient care. Topics such as chronic disease management, infection prevention, and rare disease recognition are relevant to clinicians, healthcare educators, and medical researchers. The diversity of subjects represented in her work reflects a commitment to supporting informed healthcare practice.[5]

Award Suitability

Aleksandra Kułakowska’s scholarly activities align with the objectives of the Global Innovation Technologist Awards by demonstrating engagement with healthcare innovation, medical knowledge dissemination, and interdisciplinary research. Her publication record highlights contributions to clinically relevant topics that support evidence-based practice and ongoing scientific dialogue within medicine and health sciences.[6]

Conclusion

Aleksandra Kułakowska has contributed to a range of healthcare-related subjects through peer-reviewed publications addressing patient outcomes, clinical management, and public health concerns. Her academic portfolio reflects sustained engagement with contemporary medical issues and supports the advancement of healthcare knowledge through scholarly communication.

References

  1. ORCID. (n.d.). Aleksandra Kułakowska ORCID record.
    https://orcid.org/0000-0001-5466-7167
  2. Oxford Medical Case Reports. (2025). Schnitzler syndrome – a rare cause of chronic urticaria. Case report.
    DOI: https://doi.org/10.1093/omcr/omaf118
  3. Journal of Education, Health and Sport. (2023). What impact does dialysis have on the patient’s life and mental health?
    DOI: https://doi.org/10.12775/JEHS.2023.39.01.001
  4. Journal of Education, Health and Sport. (2023). Dialysotherapy effect on the quality of life for renal patients.
    DOI: https://doi.org/10.12775/JEHS.2023.28.01.006
  5. Journal of Education, Health and Sport. (2023). Surgical site infections – an updated review of guidelines in the light of new scientific data.
    DOI: https://doi.org/10.12775/JEHS.2023.28.01.002
  6. Journal of Education, Health and Sport. (2023). Concise compilation of the most clinically relevant current knowledge on Brugada Syndrome.
    DOI: https://doi.org/10.12775/JEHS.2023.25.01.001

Karthikeyan Ramanujam | Health Professions | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Karthikeyan Ramanujam
ICMR – National Institute of Nutrition, India

Karthikeyan Ramanujam
Affiliation ICMR – National Institute of Nutrition
Country India
Scopus ID 56346958400
Documents 39
Citations 1,961
h-index 20
Subject Area Health Professions
Event Global Innovation Technologist Awards
Google Scholar ID DSsYYYEAAAAJ
Karthikeyan Ramanujam is a Scientist-C affiliated with the Indian Council of Medical Research and the ICMR–National Institute of Nutrition, Hyderabad, India. His scholarly contributions span epidemiology, biostatistics, diarrhoeal disease research, child health, nutrition, and public health analytics. The research portfolio associated with his Scopus profile demonstrates sustained engagement in internationally collaborative health studies focused on low-resource settings and population-based disease surveillance.[1]

The recognition associated with the Innovative Research Award acknowledges contributions to evidence-based public health research, multidisciplinary epidemiological investigations, and global child health studies. His publications in internationally recognized journals including The Lancet Global Health, BMJ Global Health, Clinical Infectious Diseases, and the New England Journal of Medicine have contributed to broader scientific understanding of enteric infections, nutritional health, and disease burden in developing regions.[2][3]

Abstract

The Innovative Research Award profile of Karthikeyan Ramanujam reflects a sustained academic contribution to epidemiology, child nutrition, infectious disease analytics, and public health research. Through collaborative investigations conducted under international and institutional health frameworks, the researcher has contributed to high-impact publications focused on diarrhoeal disease burden, enteropathogen surveillance, child growth outcomes, and nutritional epidemiology in low-resource environments. The scholarly output associated with this profile demonstrates measurable citation impact, interdisciplinary relevance, and substantial engagement in evidence-based public health initiatives.[4]

Keywords

Biostatistics; Epidemiology; Public Health; Child Nutrition; Infectious Diseases; MAL-ED Study; Enteropathogens; Global Health; Disease Surveillance; Nutritional Epidemiology.

Introduction

Global public health research increasingly relies on interdisciplinary collaborations to address infectious disease transmission, childhood nutrition, and epidemiological risk factors across vulnerable populations. Within this context, Karthikeyan Ramanujam has participated in several internationally recognized research initiatives examining the burden of enteric diseases and nutritional deficiencies among children living in resource-constrained regions.[5]

The researcher’s work is closely associated with population-level analyses involving epidemiological surveillance, statistical interpretation of clinical datasets, and longitudinal public health studies. Such investigations contribute to broader healthcare policy discussions and support evidence-driven interventions within global health systems.[6]

Research Profile

According to indexed academic records, Karthikeyan Ramanujam has contributed to 39 scholarly documents with an accumulated citation count exceeding 1,900 citations and an h-index of 20. The research profile demonstrates active participation in collaborative public health investigations involving institutions and researchers from multiple countries.[1]

  • Research specialization includes epidemiology, public health, nutritional science, and biostatistics.
  • Contributions are associated with multinational studies focused on child growth, enteric infections, and environmental enteropathy.
  • Publications appear in peer-reviewed journals with global readership and recognized scientific impact metrics.
  • Research activity demonstrates engagement with evidence-based healthcare analysis and population health methodologies.

Research Contributions

The researcher has contributed to major studies evaluating quantitative molecular diagnostic approaches for identifying enteropathogen-related diarrhoeal diseases among children in low-resource settings. These studies provided insights into disease etiology, pathogen burden, and associated clinical outcomes through advanced molecular diagnostic frameworks.[2]

Additional work explored the relationship between enteropathogen exposure and childhood linear growth outcomes, highlighting associations between repeated infections, nutritional status, and developmental health indicators. The findings contributed to the scientific understanding of environmental enteropathy and pediatric growth impairment.[3]

Research involvement in the MAL-ED birth cohort studies further supported the investigation of intestinal permeability, inflammation pathways, dietary intake patterns, and cognitive development in early childhood populations. These contributions are relevant to both clinical epidemiology and global nutrition policy frameworks.[7]

Publications

Selected publications associated with the research profile include the following high-impact contributions:

  • Platts-Mills JA et al. “Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings.” The Lancet Global Health, 2018.[2]
  • Rogawski ET et al. “Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings.” The Lancet Global Health, 2018.[3]
  • Kosek MN et al. “Causal pathways from enteropathogens to environmental enteropathy.” EBioMedicine, 2017.[5]
  • Amour C et al. “Epidemiology and Impact of Campylobacter Infection in Children in 8 Low-Resource Settings.” Clinical Infectious Diseases, 2016.[6]
  • John J et al. “Burden of typhoid and paratyphoid fever in India.” New England Journal of Medicine, 2023.[8]

Research Impact

The academic impact associated with this research profile is reflected through substantial citation performance and participation in influential multinational studies. Citation counts exceeding 1,900 citations indicate consistent scholarly engagement and utilization of the research findings by the broader scientific community.[1]

The integration of epidemiological analytics with nutritional and infectious disease research has supported evidence-based policy discussions related to child health interventions, disease prevention strategies, and healthcare resource allocation in low-income regions. Several publications associated with the profile have become widely referenced contributions within global public health literature.[2][5]

Award Suitability

The Innovative Research Award recognizes scholarly excellence, measurable scientific impact, and contributions that support advancements in research-driven innovation. The academic profile of Karthikeyan Ramanujam aligns with these criteria through sustained involvement in internationally collaborative health studies, impactful publication records, and contributions to epidemiological and nutritional science research.[4]

The demonstrated ability to contribute to multidisciplinary investigations addressing global child health challenges further supports recognition within international academic and scientific award platforms. The combination of citation performance, institutional affiliation, and peer-reviewed publication history reinforces the significance of the researcher’s scientific contributions.[8]

Conclusion

Karthikeyan Ramanujam has established a research profile characterized by collaborative public health scholarship, epidemiological analysis, and evidence-based contributions to global child health research. Through publications addressing enteric infections, nutrition, disease burden, and developmental outcomes, the researcher has contributed to advancing scientific understanding in health professions and epidemiological sciences.

The Innovative Research Award profile recognizes these contributions within the broader context of scientific innovation, multidisciplinary collaboration, and measurable academic impact. The body of work associated with this profile demonstrates continued relevance to international public health research initiatives and healthcare policy development.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Karthikeyan Ramanujam, Author ID 56346958400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56346958400
  2. Platts-Mills JA et al. (2018). Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings. The Lancet Global Health, 6(12), e1309-e1318.
    https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(18)30349-8/fulltext
  3. Rogawski ET et al. (2018). Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings. The Lancet Global Health, 6(12), e1319-e1328.
  4. Global Innovation Technologist Awards. (n.d.). Innovative Research Award recognition platform and scientific excellence framework.
    innovationtechnologist.com
  5. Kosek MN et al. (2017). Causal pathways from enteropathogens to environmental enteropathy: findings from the MAL-ED birth cohort study. EBioMedicine, 18, 109-117.
    https://doi.org/10.1016/j.ebiom.2017.02.024
  6. Amour C et al. (2016). Epidemiology and Impact of Campylobacter Infection in Children in 8 Low-Resource Settings: Results From the MAL-ED Study. Clinical Infectious Diseases, 63(9), 1171-1179.
    https://doi.org/10.1093/cid/ciw542
  7. McCormick BJJ et al. (2019). Intestinal permeability and inflammation mediate the association between nutrient density of complementary foods and biochemical measures of micronutrient status in young children. The American Journal of Clinical Nutrition, 110(4), 1015-1025.
    https://www.sciencedirect.com/science/article/pii/S000291652201276X
  8. John J et al. (2023). Burden of typhoid and paratyphoid fever in India. New England Journal of Medicine, 388(16), 1491-1500.
    https://www.nejm.org/doi/full/10.1056/NEJMoa2209449

Mutinda Cleophas Kyama | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Research Excellence Award

Cleophas Mutinda Kyama
Jomo Kenyatta University of Agriculture and Technology, Kenya
Cleophas Mutinda Kyama
Affiliation Jomo Kenyatta University of Agriculture and Technology
Country Kenya
Scopus ID 57216717397
Documents 65
Citations 2,698
h-index 29
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-6459-1514

Cleophas Mutinda Kyama is a Kenyan biomedical scientist, clinical cytologist, and academic researcher associated with the Jomo Kenyatta University of Agriculture and Technology (JKUAT). His scholarly contributions span cancer biology, molecular diagnostics, parasitology, toxicology, infectious disease detection, and translational biomedical sciences. His publication record demonstrates sustained engagement in interdisciplinary health science research with applications in oncology, infectious diseases, immunology, and molecular medicine.[1] The researcher has received significant scholarly attention through citations and collaborative biomedical investigations, particularly in cervical cancer diagnostics, phytomedicine, CRISPR-based diagnostic technologies, and antivenom development.[2]

Abstract

The Research Excellence Award recognition article documents the scholarly achievements and biomedical research contributions of Cleophas Mutinda Kyama. His scientific portfolio encompasses molecular diagnostics, oncology, pharmacological investigations, parasitology, immunological research, and translational health sciences. Through peer-reviewed publications, collaborative international research, and laboratory-based innovations, Kyama has contributed to the advancement of diagnostic technologies and therapeutic investigations relevant to public health challenges in Africa and globally.[3] The researcher’s work demonstrates integration of computational biology, molecular docking, in vitro experimentation, and nanotechnology-assisted diagnostics, reflecting contemporary interdisciplinary scientific approaches.[4]

Keywords

Biomedical Sciences; Molecular Diagnostics; Cervical Cancer Research; CRISPR-Cas12a; Oncology; Cytology; Antivenom Research; Pharmacology; Translational Medicine; Public Health Research; Cancer Therapeutics; Computational Biology.

Introduction

Biomedical and translational health sciences have increasingly relied upon interdisciplinary approaches integrating molecular biology, computational modeling, immunology, and experimental medicine. Within this scientific landscape, Cleophas Mutinda Kyama has contributed to research efforts addressing infectious diseases, cancer diagnostics, toxicology, and therapeutic screening technologies.[5] His work has emphasized practical healthcare applications, particularly within African biomedical contexts where diagnostic accessibility and disease management remain major public health priorities.

Kyama’s research trajectory demonstrates sustained engagement in clinically relevant investigations involving HPV-associated cervical cancer screening, SARS-CoV-2 detection systems, phytochemical anticancer studies, and venom toxicology. Several of his investigations combine computational methodologies with laboratory validation, contributing to evidence-based biomedical innovation and translational healthcare research.[6]

Research Profile

Cleophas Mutinda Kyama served at Jomo Kenyatta University of Agriculture and Technology as a Biomedical Scientist and Senior Lecturer in Medical Laboratory Sciences. His academic and professional work has focused on laboratory diagnostics, cytology, cancer biology, molecular therapeutics, and pathogen detection technologies.[1]

The researcher’s Scopus profile reports 65 scholarly documents with 2,698 citations and an h-index of 29, reflecting measurable scientific visibility and sustained citation impact across biomedical disciplines.[1] His work has appeared in journals including PLOS ONE, BMC Complementary Medicine and Therapies, Diagnostics, Toxicon: X, Toxins, and the South African Journal of Botany.

  • Research specialization in molecular diagnostics and biomedical laboratory sciences.
  • Interdisciplinary research combining computational biology and experimental medicine.
  • Published investigations involving oncology, toxicology, parasitology, and virology.
  • Contributions to public health-oriented biomedical innovation.

Research Contributions

Among Kyama’s notable scientific contributions are investigations into cervical cancer therapeutics and molecular screening technologies. His 2025 study in PLOS ONE explored the molecular mechanisms of Solanecio mannii aqueous root extracts against cervical cancer using computational and experimental validation methodologies.[2]

Additional research explored network pharmacology and molecular docking strategies for prostate cancer treatment investigations using Aspilia pluriseta. These studies integrated in vitro analysis with computational biology techniques to evaluate antiproliferative activity and potential therapeutic mechanisms.[3]

Kyama also contributed to advanced infectious disease diagnostics through CRISPR-Cas12a and hybridization chain reaction methodologies for SARS-CoV-2 detection. This work reflected the growing importance of rapid molecular diagnostic systems during global public health emergencies.[4]

In toxicological and immunological sciences, his studies investigated venom lethality, monoclonal antibody development, and antivenom efficacy involving Naja ashei toxins. These investigations contributed to understanding envenomation management and toxin-neutralizing biomedical strategies.[7]

Publications

Selected publications associated with Cleophas Mutinda Kyama include peer-reviewed journal articles, preprints, and translational biomedical studies relevant to oncology, diagnostics, toxicology, and parasitology.

  1. Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE (2025).
  2. Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complementary Medicine and Therapies (2024).
  3. Application of Hybridization Chain Reaction/CRISPR-Cas12a for the Detection of SARS-CoV-2 Infection. Diagnostics (2023).
  4. Evaluation of lethality and cytotoxic effects induced by Naja ashei venom and efficacy of selected antivenoms in Kenya. Toxicon: X (2022).
  5. Development and Characterization of Anti-Naja ashei Three-Finger Toxins-Specific Monoclonal Antibodies. Toxins (2022).

Research Impact

The scientific impact of Cleophas Mutinda Kyama’s work is reflected through citation metrics, interdisciplinary collaborations, and practical biomedical applications. His investigations into molecular diagnostics and therapeutic evaluation contribute to contemporary discussions surrounding affordable healthcare technologies, precision diagnostics, and evidence-based medicinal research.[4]

Research involving CRISPR-based diagnostics and nanoparticle-assisted detection systems demonstrates alignment with emerging biomedical technologies that support rapid pathogen identification and translational healthcare innovation.[8] Similarly, his toxicological and antivenom studies address healthcare concerns related to snakebite management in endemic regions.

The integration of phytomedicine, computational molecular analysis, and laboratory validation techniques further reflects a multidisciplinary scientific framework capable of supporting future biomedical innovation and collaborative translational research initiatives.[3]

Award Suitability

The scholarly profile of Cleophas Mutinda Kyama demonstrates characteristics associated with international academic recognition and research excellence awards. His documented publication history, citation impact, interdisciplinary biomedical investigations, and sustained engagement in translational health sciences collectively support recognition within the framework of the Global Innovation Technologist Awards.[1]

  • Demonstrated publication productivity in indexed scientific journals.
  • Strong citation impact and measurable academic influence.
  • Contributions to molecular diagnostics and translational medicine.
  • Interdisciplinary biomedical innovation relevant to public health.
  • Research engagement involving computational and experimental methodologies.

Conclusion

Cleophas Mutinda Kyama has established a research profile characterized by interdisciplinary biomedical inquiry, molecular diagnostic innovation, and translational scientific investigations addressing major health challenges. His academic contributions in oncology, toxicology, molecular biology, and infectious disease diagnostics demonstrate sustained scholarly engagement and measurable scientific impact.[5] Through collaborative biomedical research and publication activity, his work contributes to evolving scientific understanding within medicine and health sciences while supporting broader healthcare research objectives relevant to emerging global health priorities.

References

  1. Elsevier. (n.d.). Scopus author details: Cleophas Mutinda Kyama, Author ID 57216717397. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57216717397
  2. Kyama, C. M. et al. (2025). Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE.
    https://doi.org/10.1371/journal.pone.0323680
  3. Kyama, C. M. et al. (2024). Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complementary Medicine and Therapies.
    https://doi.org/10.1186/s12906-024-04642-8
  4. Kyama, C. M. et al. (2023). Application of Hybridization Chain Reaction/CRISPR-Cas12a for the Detection of SARS-CoV-2 Infection. Diagnostics.
    https://doi.org/10.3390/diagnostics13091644
  5. Jomo Kenyatta University of Agriculture and Technology. (n.d.). Medical Laboratory Sciences and Biomedical Research Activities.
  6. Kyama, C. M. et al. (2022). Expression of the Fab enzymes from Plasmodium falciparum after exposure to Artemisia afra plant extracts. Journal of Parasitic Diseases.
    https://doi.org/10.1007/s12639-022-01537-8
  7. Kyama, C. M. et al. (2022). Development and Characterization of Anti-Naja ashei Three-Finger Toxins-Specific Monoclonal Antibodies. Toxins.
    https://doi.org/10.3390/toxins14040285
  8. Kyama, C. M. et al. (2020). Development of HPV 16/18 E6 oncoprotein paper-based nanokit for enhanced cervical cancer screening.
    https://doi.org/10.1101/2020.04.29.20084459

Chin Pyng Wu | Health Professions | Breakthrough Research Award

Published on by Innovation Technologist

Prof. Dr. Chin Pyng Wu | Health Professions | Breakthrough Research Award

Landseed International Medical | Taiwan

Prof. Dr. Chin Pyng Wu is a distinguished researcher in pulmonary and critical care medicine, with a strong focus on prolonged mechanical ventilation, respiratory care systems, and healthcare resource optimization. His research integrates clinical epidemiology with healthcare policy, contributing to advancements in ventilator-dependent patient management and weaning strategies. He has played a key role in evaluating integrated care models, particularly in improving outcomes and reducing ICU burden. His scholarly work spans journal publications, collaborative research projects, and contributions to evidence-based respiratory care practices. His research impact is reflected in high citation metrics and sustained contributions to clinical innovation and healthcare system improvement.

                            Citation Metrics (Scopus)

3000

2500

2000

1500

1000

500

0

 

Citations
1969
Documents
98
h-index
25

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Soraia Pereira | Nursing and Health Professions | Research Excellence Award

Published on by Innovation Technologist

Prof. Soraia Pereira | Nursing and Health Professions | Research Excellence Award

School of Nursing, University of Porto | Portugal

Prof. Soraia Pereira is an emerging researcher in nursing sciences, focusing on nursing practice environments, patient safety, and healthcare quality improvement. Her work integrates evidence-based practice, artificial intelligence in nursing, and organizational factors influencing clinical outcomes. She has contributed to systematic reviews, randomized trials, and concept analyses addressing professional environments and safety culture in healthcare systems. Her research advances interdisciplinary collaboration, workforce empowerment, and innovation in care delivery. She actively participates in international research networks and contributes to scientific dissemination through peer review and editorial activities, supporting the advancement of nursing knowledge and evidence-based healthcare practices globally.

                            Citation Metrics (Scopus)

300

250

200

150

100

50

0

 

Citations
169
Documents
21
h-index
8

Citations

Documents

h-index

View Scopus Profile  View ORCID Profile

Featured Publications

Catherine Frenkel | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Dr. Catherine Frenkel | Medicine and Health Sciences | Research Excellence Award

Levine Cancer Institute | United States

Dr. Catherine Frenkel is a surgeon-scientist specializing in head and neck oncology, surgical innovation, and clinical ethics. Her research integrates oncologic outcomes with ethical frameworks, particularly in areas such as robotic surgery, telesurgery, and decision-making in complex cancer care. She has contributed significantly to enhanced recovery after surgery (ERAS) protocols and multidisciplinary cancer treatment optimization. Her work also explores ethical challenges in transplantation and AI integration in surgical practice. Dr. Catherine Frenkel is actively involved in clinical research as a principal investigator, focusing on improving patient outcomes and healthcare delivery through evidence-based and ethically grounded innovations in surgical oncology.

                            Citation Metrics (Scopus)

300

250

200

150

100

50

0

 

Citations
197
Documents
20
h-index
7

Citations

Documents

h-index

View Scopus Profile  View Google Scholar Profile  View ORCID Profile

Featured Publications

Jatinder Kumar | Health Care Services | Best Researcher Award

Published on by Innovation Technologist

Dr. Jatinder Kumar | Health Care Services | Best Researcher Award

IT Professional at PGIMER, Chandigarh, India

Dynamic IT professional with over 25 years of experience in software development, network infrastructure, and IT solutions. Specializes in full-stack development, cloud computing (AWS, Azure), network security, and virtualization technologies. Experienced in integrating business strategy with technology to enhance IT operations. Holds extensive expertise in hospital information systems, data analytics, and artificial intelligence applications in healthcare.

Publication Profile 

Scopus

Educational Background 🎓

  • PhD in Computer Science, Chitkara University (2024)
  • Master of Philosophy (Computer Science), MMU, Sadopur, Ambala, Haryana (2013)
  • Master of Business Administration (MBA), Panjab University, Chandigarh (2006)
  • Master of Computer Applications (MCA), Panjab University, Chandigarh (1997)
  • Bachelor of Science (B.Sc.), M.A.M. College, Jammu (1994)

Professional Experience 💼

  • Software Engineer, Trident InfoTech Corporation Limited, Chandigarh
    • Developed software solutions and contributed to system design and deployment.
    • Worked on enterprise-level applications for various industries.
  • Computer Programmer, PGIMER, Chandigarh (Since 2001)
    • Key contributor to the implementation of the Hospital Information System (HIS) for a 2,500-bed hospital.
    • Designed and developed the inventory module using process flow diagrams and entity-relationship diagrams.
    • Enhanced patient care, reduced wait times, and streamlined administrative workflows.
    • Involved in system integration, cloud-based solutions, and data migration strategies.

Research Interests 🔬

  • Artificial intelligence and deep learning applications in healthcare.
  • Medical imaging and thyroid nodule analysis using deep learning models.
  • Multi-agent system frameworks for efficient hospital administration.
  • Cloud computing and security solutions for healthcare IT systems.
  • e-Governance and digital transformation in public healthcare.

Awards and Honors🏆✨

  • Best Paper Presentation, TELEMEDICON 2024, PGIMER, Chandigarh.
  • Best Paper Presentation, ICAAIML 2024, Hyderabad, India.
  • First Prize in Yoga Competition, International Yoga Day 2024, PGIMER, Chandigarh.
  • Represented Chandigarh in National Yoga Competitions in Telangana and Rajasthan.
  • Conducting yoga classes and educational support for underprivileged children in Chandigarh.
  • Various professional certifications in hardware, Oracle, and MCSE.

Conclusion🌟

With an extensive background in IT, healthcare systems, and artificial intelligence, the author has made significant contributions to hospital information systems and deep learning applications in medical imaging. His research and professional work have enhanced patient care and operational efficiency in healthcare institutions. Recognized for academic excellence and community service, he continues to drive innovation in AI-driven healthcare solutions and IT infrastructure development.

Publications 📚

📖 Kumar, J., Panda, S.N., & Dayal, D. (2023, December). Deep Learning for Improved Thyroid Nodule Analysis in Ultrasound Images. INTERNATIONAL JOURNAL OF RESEARCH AND ANALYTICAL REVIEWS (IJRAR.ORG), Volume 10, Issue 4.

📖 Kumar, J., Panda, S.N., & Dayal, D. (2023). Utilizing Deep Learning Models for the Classification of Thyroid Nodules in Ultrasound Images. The International Journal of Engineering and Science (IJES), Volume 12, Issue 11, Pages 18-31.

📖 Kumar, J., Panda, S.N., & Dayal, D. (2023, December). An Overview of Deep Learning Methods for Segmenting Thyroid Ultrasound Images. International Journal of Advanced Engineering and Nano Technology (IJAENT), ISSN: 2347-6389 (Online), Volume 10, Issue 12.

📖 Kumar, J., Panda, S.N., Dayal, D., & Sharma, M. (2024). Enhancing Thyroid Nodule Assessment with Deep Learning and Ultrasound Imaging. e-Prime – Advances in Electrical Engineering, Electronics, and Energy (Scopus). (Submitted after revision, awaiting acceptance letter.)

🎙️ Kumar, J., Panda, S.N., & Dayal, D. (2023, November). Deep learning routes to thyroid ultrasound image segmentation: A review. AIP Conference Proceedings, Vol. 2878, No. 1. AIP Publishing.

🎙️ Kumar, J., Panda, S.N., Dayal, D., & Sharma, M. (2023, September). Review of Deep Learning Techniques Over Thyroid Ultrasound Image Segmentation. 2023 International Conference on Sustainable Emerging Innovations in Engineering and Technology (ICSEIET), pp. 320-326. IEEE.

🎙️ Kumar, J., Panda, S.N., & Dayal, D. (2023). Pediatric Thyroid Ultrasound Image Classification Using Deep Learning: A Review. Chitkara University Doctoral Consortium – CUDC 2023.

🎙️ Kumar, J., Panda, S.N., & Dayal, D. (2024). Improving Thyroid Nodule Evaluation Using Deep Learning and Ultrasound Imaging. National Telemedicine Conference – TELEMEDICON 2024, held in Chandigarh (November 28-30, 2024).